0001437749-24-011108.txt : 20240404 0001437749-24-011108.hdr.sgml : 20240404 20240404175228 ACCESSION NUMBER: 0001437749-24-011108 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240404 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slover Peter T CENTRAL INDEX KEY: 0001468012 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 24824230 MAIL ADDRESS: STREET 1: 3115 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Contineum Therapeutics, Inc. CENTRAL INDEX KEY: 0001855175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271467257 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-5280 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Pipeline Therapeutics, Inc. DATE OF NAME CHANGE: 20210405 3 1 rdgdoc.xml FORM 3 X0206 3 2024-04-04 0 0001855175 Contineum Therapeutics, Inc. CTNM 0001468012 Slover Peter T 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 1 Chief Financial Officer Stock Option (right to buy) 1.0100 2030-10-05 Class A Common Stock 144715 D Stock Option (right to buy) 8.4500 2031-03-15 Class A Common Stock 39305 D Stock Option (right to buy) 10.8000 2033-10-08 Class A Common Stock 53598 D Options granted under the Issuer's 2012 Equity Incentive Plan (the "Plan"). The option is fully vested. Options granted under the Plan. 25% of the options vest on March 11, 2022 and an additional 1/48th of the options vest monthly thereafter for a period of 3 years, subject to the Reporting Person's continuous service. Options granted under the Plan. 25% of the options vest on September 27, 2024 and an additional 1/48th of the options vest monthly thereafter for a period of 3 years, subject to the Reporting Person's continuous service. Exhibit 24 - Power of Attorney /s/ Peter Slover 2024-04-04 EX-24 2 slover_poa.htm EXHIBIT 24 - POWER OF ATTORNEY ex_648105.htm

Exhibit 24

 

Pipeline Therapeutics, Inc. – Power of Attorney

 

KNOW ALL BY THESE PRESENTS, the undersigned hereby constitutes and appoints Carmine Stengone, signing singly, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

 

(1)

execute for and on behalf of the undersigned a Form ID Application, if required, and submit the same to the United States Securities and Exchange Commission;

 

(2)

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Pipeline Therapeutics, Inc. (the “Company”) or as a holder of 10% or more of the Company’s securities, Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder and, if necessary, such forms or similar reports required by state or foreign regulators in jurisdictions in which the Company operates;

 

(3)

do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5 or similar form or report required by state or foreign regulators, and any amendments thereto, and file such form or report with the United States Securities and Exchange Commission and any stock exchange or similar authority or appropriate state or foreign regulator; and

 

(4)

take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally required to be done by the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder. This Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

 

Date: March 22, 2021

 

By: /s/ Peter Slover
Name: Peter Slover